Hormone Therapy and Facial Planning in HOF: Waiting Time
Quick facts
- Core idea
- Hormones change the face slowly. Treating too early means planning on a moving target.
- Scenarios
- Menopausal hormone therapy, gender-affirming hormone therapy, and hormones used for other clinical reasons.
- Principle
- Wait for signs of stabilization when possible, treat what the patient wants most at the lowest risk, and reassess in stages.
- Respect
- Use the right language, avoid unnecessary curiosity, and do not assume what the patient wants.
Hormones affect the skin, fat and healing, and that shows on the face. When a patient starts or continues hormone therapy, the face is not the same as three months ago and will not be the same six months from now. Planning a harmonization without taking that movement into account is drawing on a target that keeps shifting.
This page covers planning reasoning in two common scenarios: menopausal hormone therapy and gender-affirming hormone therapy. It does not prescribe or evaluate hormone therapies, which belong to the treating physician. For the context of each group, see menopause and facial aging in HOF, facial feminization with injectables, facial masculinization with injectables and respectful care for trans patients in HOF.
What do hormones change in the face?
The effects depend on the type of hormone, the dose, how long it has been used, age and individual predisposition. In general terms, influence is described on:
| Tissue | Possible effect of hormones | Implication for the plan |
|---|---|---|
| Skin | Changes in thickness, hydration, oiliness and elasticity | The response to biostimulators and skin boosters may vary |
| Facial fat | Gradual redistribution | The ideal volume changes over time |
| Healing and inflammation | May change with the dose and the clinical condition | Affects swelling, bruising and risk of nodules |
| Hair | Changes in beard and hairline | Interferes with the perception of contour and with area planning |
| Water and swelling | Variation with the cycle and with medication | The face may be more or less swollen |
Some of these effects set in within weeks; others take months to years to settle. Attributing a change to a specific hormone is difficult, and it is prudent to speak of a tendency.
Menopausal hormone therapy
Menopause brings collagen loss, changes in skin thickness and fat redistribution, which add to natural aging. Patients on hormone therapy may report better skin quality, but the effect on volume and support is limited and variable.
For planning:
- Focus on the concern: volume loss, laxity, skin texture, lines, contour. See menopause and facial aging in HOF.
- Consider collagen stimulation as part of the plan, with realistic expectations. See biostimulators: overview.
- Ask about other medications that affect bleeding and clotting.
- Be careful with the weight and mood changes that come with this phase.
- Offer support. Many patients arrive distressed about the changes and expect to be heard.
Gender-affirming hormone therapy
For trans and nonbinary people, the face plays an important role in identity and well-being, and harmonization can be part of care. Hormone therapy brings changes to skin, fat and hair over months and years, but it does not change bone or many proportions that are already set.
A few points for the professional:
- The goal is the patient's. Ask what they want to change and what they feel comfortable keeping. Avoid imposing binary standards of beauty.
- Correct language. Use the name and pronouns the patient indicates, and record this in the patient record if they allow it.
- Unnecessary curiosity. Questions about surgeries, genitals or personal history are only appropriate if they are clinically relevant. See HOF consultation with a trans patient.
- Time and stages. Because the face changes with hormone therapy, the plan is usually staged. Some areas can wait; others bring immediate relief from dysphoria and deserve priority.
- Work as a team. The endocrinologist, the psychologist and other professionals may take part in care. Referral is part of the job.
- Confidentiality. The condition and the use of hormones are sensitive data.
The approaches by area, such as chin, jaw, cheekbone, forehead and lips, are in facial feminization with injectables and facial masculinization with injectables, without an injection protocol.
When to wait and when to act?
There is no single clock, but some criteria help decide:
- Speed of change. If the face is changing quickly, the tendency is to wait before adding volume. If the change has slowed, planning is safer.
- The patient's distress. In dysphoria or intense distress, waiting too long has an emotional cost. Low-risk, reversible procedures can be a bridge.
- Risk of the procedure. The more irreversible and higher-risk it is, the more reason to wait and confirm stability.
- Goal. Some concerns (lines, skin quality) are less sensitive to timing than others (volume, contour).
- Autonomy. The informed patient decides, within what is safe and indicated.
| Situation | Tendency of approach |
|---|---|
| Recently started hormones, face changing quickly | Prioritize what is reversible or low risk; postpone large volumes |
| Stable use for some time, slow changes | Plan with more confidence, in stages |
| Specific concern causing intense distress | Consider a targeted, conservative intervention, with reassessment |
| Recent change in dose or type of hormone | Reassess the trend before deciding |
| Menopause in transition with fluctuations | Monitor and treat clear concerns, without excess |
What should you record, and how do you align expectations?
In the patient record, note the hormone therapy reported (type and duration of use, if the patient wishes to share), the patient's goal, the changes noticed, the staged plan and the consent. Standardized photos at regular intervals help show the path of the face; see standardized clinical photography. Reinforce that the plan can be adjusted and that the face will keep changing.
And in Harmy?
Summary
Hormones keep the face in motion. Ask, observe with photos, plan in stages and respect the patient's goal and identity. Prefer the reversible and the conservative while the change is fast, refer what belongs to the treating physician and protect confidentiality.
Frequently asked questions
Can someone on hormone therapy have facial harmonization?
In general, yes, after an assessment. The professional needs to understand the type of hormone, how long it has been used, the patient's goal and the way the face is likely to change. Volumes and touch-ups are usually planned in stages.
How long should you wait after starting hormones before harmonizing?
There is no single timeframe. Some changes in skin and fat appear over months and keep going for longer. The wait depends on the goal, the speed of the changes and what the patient can bear to wait.
Does menopausal hormone therapy change harmonization?
It can influence skin quality and the pace of change, but the effect varies from person to person. Planning takes into account age, volume loss and what the patient wants, and does not depend only on hormone use.
Does gender-affirming hormone therapy replace harmonization?
It does not replace it. Hormones bring gradual changes in the skin and in fat distribution, but bone shape and many proportions do not change. Facial procedures can complement it, depending on the patient's wishes and the assessment.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.